Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia

Angiotensin converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) are recommended for secondary prevention in peripheral artery disease, but their effectiveness in patients with critical limb ischemia (CLI) is uncertain. We reviewed 464 patients with CLI who underwent diagnost...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Vascular medicine (London, England) Ročník 20; číslo 3; s. 237 - 244
Hlavní autoři:	Armstrong, Ehrin J, Chen, Debbie C, Singh, Gagan D, Amsterdam, Ezra A, Laird, John R
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London, England SAGE Publications 01.06.2015 Sage Publications Ltd
Témata:	Aged Angiotensin Receptor Antagonists - therapeutic use Angiotensin-Converting Enzyme Inhibitors - therapeutic use Cardiovascular Diseases - etiology Cardiovascular Diseases - prevention & control Critical Illness Female Follow-Up Studies Humans Ischemia - complications Leg - blood supply Male Proto-Oncogene Proteins Receptors, G-Protein-Coupled Retrospective Studies Time Factors peripheral artery disease critical limb ischemia guideline therapies adherence angiotensin converting enzyme inhibitor angiotensin receptor blocker prevention
ISSN:	1358-863X, 1477-0377
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!